In 2019, Hellstrom et al. [45] published an interesting study describing the results obtained by using four different anti-HE4 mouse antibodies (mAbs) to characterize the different isoforms of the HE4 protein in ovarian cancer cells and in the blood of women affected by these neoplasms. Here, WFDC2 is linked to ovarian cancer.